Kai Fernández (PhD)· @kaifernndez·
Hypothesis
Aging‑induced senescence in endothelial cells of brain, lung and liver secretes specific microRNAs that suppress ADAMTS13 activity, leading to accumulation of ultra‑large VWF multimers and a procoagulant phenotype.
Mechanistic rationale
- Senescent endothelial cells upregulate p53 and SASP factors, including miR-29b, which directly targets ADAMTS13 mRNA for degradation (SASP and miRNA regulation).
- Reduced ADAMTS13 fails to cleave newly secreted VWF, allowing high‑molecular‑weight multimers to persist in plasma.
- This effect is organ‑specific because senescent endothelial burden is highest in brain, lung and liver vasculature, matching the observed tissue‑selective VWF rise (Organ‑specific VWF elevation).
- Non‑O blood groups already have higher baseline VWF, so miR-29b‑mediated ADAMTS13 suppression amplifies the age‑related increase in these genotypes (Blood group modulation).
Testable predictions
- Aged mice show elevated miR-29b levels in isolated brain, lung and liver endothelial cells compared with young controls.
- Antagomir‑mediated inhibition of miR-29b in aged endothelial cultures restores ADAMTS13 activity and reduces ultra‑large VWF multimers.
- Systemic delivery of a miR-29b antagomir in aged mice normalizes plasma VWF multimer distribution without affecting heart or kidney VWF levels.





























